Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact

Andrea S Lukes; Rezan A Kadir; Flora Peyvandi; Peter A Kouides

doi:10.1016/j.fertnstert.2005.04.061

Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact

Fertil Steril. 2005 Nov;84(5):1338-44. doi: 10.1016/j.fertnstert.2005.04.061.

Authors

Andrea S Lukes¹, Rezan A Kadir, Flora Peyvandi, Peter A Kouides

Affiliation

¹ Women's Hemostasis and Thrombosis Clinic, Duke University Medical Center, Durham, North Carolina 27710, USA. [email protected]

PMID: 16275227
DOI: 10.1016/j.fertnstert.2005.04.061

Abstract

The prevalence and impact of most underlying disorders of hemostasis are reviewed in women with excessive menstrual bleeding. The most common underlying bleeding disorder is von Willebrand disease, which occurs in only 1% to 2% of the general population but in approximately 13% of women with excessive menstrual bleeding.

Publication types

Review

MeSH terms

Blood Coagulation Disorders / blood
Blood Coagulation Disorders / epidemiology*
Blood Coagulation Disorders / therapy
Female
Hemorrhage / blood
Hemorrhage / epidemiology
Hemorrhage / therapy
Hemostasis*
Humans
Menorrhagia / blood
Menorrhagia / epidemiology*
Menorrhagia / therapy
Menstruation* / blood
Prevalence
von Willebrand Diseases / blood
von Willebrand Diseases / epidemiology
von Willebrand Diseases / therapy